Bactolife uses its proprietary Binding Protein technology to develop novel biological solutions, strengthening the gut microbiome and helping solve the daunting challenge of antimicrobial resistance (AMR) development, as well as the general burden of infectious diseases. Its proprietary platform consists of a technology for selecting and producing Binding Proteins that acts on toxins without targeting …

Solu is building a bacterial DNA database, enabling the analysis, monitoring, and control of antibiotic-resistant bacteria. Its software makes it easier to understand, detect, and prevent the spread of antibiotic resistance and enables the development of new treatment methods against resistant bacteria. The company is collaborating with top international universities, including Stanford University and the …